Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
McKinsey
Pharma
Does the Q4 M&A binge foreshadow a boom year for deals in 2026?
Of the top 10 biopharma M&A deals of 2025, six came in the fourth quarter. Will the surge continue in 2026? Many industry watchers believe so.
Kevin Dunleavy
Dec 24, 2025 5:00am
Consultant McKinsey to pay $650M in federal opioid settlement
Dec 13, 2024 1:58pm
The best returns come from small M&A deals: McKinsey report
Apr 9, 2024 10:45am
'The Top Line’: Closing the $1 trillion women’s health gap
Jan 26, 2024 9:23am
Klick adds head of new commercial solutions business
Jan 9, 2023 7:25am
Pfizer recruits new top dealmaker from McKinsey
Aug 26, 2021 8:00am
